Simultaneously, ATF3 enhances cellular antioxidant capacity by regulating the expression of SLC7A11, alleviating intestinal ischemia-reperfusion injury and inhibiting ferroptosis (48). The gene discussed is SLC7A11; the disease is ischemia.